A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer
Clinical trial NCT00116779 · COMPLETED
Trial details
- NCT number
- NCT00116779
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2005-08-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.